There is a professional organization for nearly every segment of health care, each typically publishing papers and articles on their specific area of focus. These publications are invaluable sources of information that also enable us to produce our Reports.
Recently, we have concentrated on cell and gene therapy due to significant advancements and activity within this field a segment of great interest for manufacturers, and payers alike. This sector has seen the emergence of new companies, technological breakthroughs, and even cures for certain diseases.
In this context, we introduce the American Society of Gene and Cell Therapy (ASGCT). Notably, ASGCT recently hosted their Annual Meeting in New Orleans. Unlike many annual gatherings, it is highly likely that the various presentations were well attended, given the rapid pace of developments in this field. Every scrap of new research or new technology could hold substantial value.
The accompanying article is recommended for a brief read to pique your interest. It highlights how several companies are positioning themselves to revolutionize the industry, moving towards a future where personalized, effective treatments for complex diseases are increasingly attainable. We will be on alert for other articles tackling the other remaining, thorny issue….. affordability.
—————————————————————————————–